Among those, PI3K-Akt, MAPK/Erk, and p53 signaling pathways were selected for further investigation based on the previous KEGG pathway enrichment analysis of the 123 core targets for DSD. The gene discussed is TP53; the disease is disorder of sexual differentiation.